The GLP-1 Receptor Agonist Liraglutide Improves Hepatic Inflammation and Fibrosis in a Mouse Model of NASH

被引：3
|
作者：
Montandon, Sophie A.
Somm, Emmanuel
De Vito, Claudio
Jornayvaz, Francois R.
机构：
来源：
DIABETES | 2019年 / 68卷
关键词：
D O I：
10.2337/db19-1887-P
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1887-P
引用
收藏
页数：2
相关论文
共 50 条
  • [1] GLP-1 agonist liraglutide improves insulin sensitivity
    Di Lellis, Maddalena Angela
    DIABETOLOGIE UND STOFFWECHSEL, 2024, 19 (03) : 172 - 172
  • [2] The GLP-1 Receptor Agonist Liraglutide Improves Autophagy Impairment in the Diabetic Heart
    Bugyei-Twum, Antoinette
    Switzer, Jennifer
    Singh, Krishna K.
    Connelly, Kim A.
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2017, 37
  • [3] The GLP-1 receptor agonist liraglutide improves glomerular filtration rate, renal inflammation and fibrosis in the type 2 diabetic SDT fatty rat
    Briand, F.
    Shinohara, M.
    Brousseau, E.
    Kageyama, Y.
    Sulpice, T.
    DIABETOLOGIA, 2020, 63 (SUPPL 1) : S392 - S392
  • [4] The GLP-1 Receptor Agonist Liraglutide Improves Glomerular Filtration Rate, Renal Inflammation, and Fibrosis in the Type 2 Diabetic SDT Fatty Rat
    Briand, Francois
    Shinohara, Masami
    Brousseau, Emmanuel
    Kageyama, Yasushi
    Sulpice, Thierry
    DIABETES, 2020, 69
  • [5] MEDI0382, a GLP-1/Glucagon Receptor Dual Agonist, Dramatically Reduces Hepatic Collagen in a Mouse Model of NASH
    Beaton, Michelle
    Guionaud, Silvia
    Conway, James P.
    Grimsby, Joe
    Rhodes, Christopher J.
    Jermutus, Lutz
    Trevaskis, James
    DIABETES, 2018, 67
  • [6] MEDI0382, a GLP-1/Glucagon Receptor Dual Agonist, Dramatically Reduces Hepatic Collagen in a Mouse Model of NASH
    Beaton, Michelle
    Guionaud, Silvia
    Conway, James P.
    Grimsby, Joe
    Rhodes, Christopher J.
    Jermutus, Lutz
    Trevaskis, James
    DIABETES, 2019, 68
  • [7] Liraglutide, GLP-1 receptor agonist, for chronic weight loss
    Moore, Katherine G.
    Shealy, Kayce
    Clements, Jennifer N.
    EXPERT REVIEW OF ENDOCRINOLOGY & METABOLISM, 2016, 11 (05) : 373 - 378
  • [8] MEDI0382, a GLP-1/glucagon receptor dual agonist, improves NASH and reduces liver fibrosis in mice
    Trevaskis, J. L.
    Boland, M. L.
    Conway, J.
    Guionaud, S.
    Grimsby, J.
    Jermutus, L.
    Rhodes, C. J.
    DIABETOLOGIA, 2018, 61 : S590 - S590
  • [9] GLP-1 receptor agonist, liraglutide, improves neovascularization by improving the function of endothelial progenitor cells
    Zheng, Chao
    Su, Yue
    DIABETES-METABOLISM RESEARCH AND REVIEWS, 2019, 35
  • [10] A long-acting GLP-1 agonist exenatide suppresses inflammation and fibrosis in models of NASH and biliary fibrosis
    Wang, Xiao-Yu
    Weng, Shih-yen
    Klein, Thomas
    Kim, Yong Ook
    Schuppan, Detlef
    HEPATOLOGY, 2013, 58 : 585A - 586A
12345